GFM
VIR icon

GF Fund Management’s Vir Biotechnology VIR Stock Holding History

GF Fund Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.9K Buy
3,327
+216
+7% +$2.06K ﹤0.01% 438
2026
Q1 		$27.9K Buy
3,111
+377
+14% +$3K ﹤0.01% 462
2025
Q4 		$16.5K Sell
2,734
-255
-9% -$1.52K ﹤0.01% 527
2025
Q3 		$17.1K Sell
2,989
-537
-15% -$2.75K ﹤0.01% 507
2025
Q2 		$17.8K Hold
3,526
– – ﹤0.01% 513
2025
Q1 		$22.8K Buy
3,526
+634
+22% +$5.64K ﹤0.01% 490
2024
Q4 		$21.2K Buy
+2,892
New +$22.8K ﹤0.01% 466

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GF Fund Management's VIR Position: Q2 2026 in Review

GF Fund Management increased its Vir Biotechnology (VIR) stake by 6.9% in Q2 2026, buying an estimated $2.06K and bringing the position to 3,327 shares worth $33.9K. The position accounts for ﹤0.01% of the portfolio, ranked #438.

GF Fund Management first reported a position in VIR in Q4 2024 and has held it in 7 quarters since. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • GF Fund Management held 3,327 shares of Vir Biotechnology worth $33.9K as of Q2 2026.
  • GF Fund Management bought 216 Vir Biotechnology shares in Q2 2026, an estimated $2.06K.
  • Vir Biotechnology made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #438 holding.
  • GF Fund Management first reported a position in Vir Biotechnology in Q4 2024 and has held it in 7 quarters since.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.